Insiders · KDNY

Alan Glicklich

Officer at Chinook Therapeutics, Inc. (KDNY)

Alan Glicklich has filed 9 insider reports with the SEC since February 2021, as director at CalciMedica, Inc. (CALC) and officer at Chinook Therapeutics, Inc. (KDNY). Alan Glicklich made no open-market purchases or sales in the last 12 months. The latest filing, on August 21, 2026, reports grant or award at CalciMedica, Inc. (CALC).

Filings
9
Companies
2
Bought on market
None
Sold on market
$357K

Companies where Alan Glicklich is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
CalciMedica, Inc. logo
CALC
CalciMedica, Inc.
Directorsince January 2025$1.26Aug 21, 2026
Chinook Therapeutics, Inc. logo
KDNY
Chinook Therapeutics, Inc.
Officer7,891$357KFeb 15, 2022

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Also sits on boards with

Officers and directors who share two or more companies with Alan Glicklich.

Compare Alan Glicklich with

Other insiders at the same companies

Questions about Alan Glicklich

What is Alan Glicklich's role at Chinook Therapeutics, Inc.?
Alan Glicklich reports to the SEC as officer at Chinook Therapeutics, Inc. (KDNY), according to the latest filing on February 15, 2022. Alan Glicklich has also filed as director at CalciMedica, Inc. (CALC).
How many shares does Alan Glicklich own?
After the latest filing that states it, Alan Glicklich directly owned 7,891 shares of Chinook Therapeutics, Inc. (KDNY). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Alan Glicklich bought or sold stock recently?
The most recent open-market sale was on February 11, 2022: sold 2,391 shares of Chinook Therapeutics, Inc. (KDNY) for $30.5K at an average of $12.74.
How do I get alerts when Alan Glicklich files?
Follow Alan Glicklich on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Alan Glicklich (SEC CIK 0001823197). Totals count each trade once, skipping amendments whose original is on file, from Feb 12, 2021 on. View on SEC EDGAR · Get this as JSON